DYNAVAX TECHNOLOGIES
Dynavax is a commercial stage biopharmaceutical company developing and commercializing novel vaccines. The Company's first commercial product, HEPLISAV-B® [Hepatitis B Vaccine (Recombinant), Adjuvanted], is approved in the U.S. and the European Union for prevention of infection caused by all known subtypes of hepatitis B virus in adults age 18 years and older. Dynavax is also advancing CpG 1018TM adjuvant as a premier vaccine adjuvant through research collaborations and partnerships. Current collaborations are focused on adjuvanted vaccines for COVID-19, pertussis and universal influenza.
DYNAVAX TECHNOLOGIES
Social Links:
Industry:
Biopharma Biotechnology Clinical Trials Health Care Medical Device
Founded:
1996-01-01
Address:
Berkeley, California, United States
Country:
United States
Website Url:
http://www.dynavax.com
Total Employee:
501+
Status:
Active
Contact:
+1 510 848 1327
Email Addresses:
[email protected]
Total Funding:
1.04 B USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics LetsEncrypt Google Universal Analytics Domain Not Resolving Apache Microsoft Exchange Online
Similar Organizations
Vero Biotech
Vero Biotech is a biopharmaceutical company developing products to address the medical needs of patients with pulmonary, cardiac diseases.
Inventiva Pharma
Inventiva is a biopharmaceutical company with several drug candidates at clinical and preclinical stage.
Aptose Biosciences
Aptose Biosciences is a biopharmaceutical company focused on the discovery, research and development of novel, first-in-class
TrioMed Innovations
TrioMed Innovations develops antimicrobial technologies and products to prevent the spreading of infections and diseases.
Vygon
Vygon offer health professionals efficient and innovative single-use medical products adapted to their needs.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2009-11-10 | Symphony Dynamo | Symphony Dynamo acquired by Dynavax Technologies | N/A |
Investors List
Coalition for Epidemic Preparedness Innovations
Coalition for Epidemic Preparedness Innovations investment in Post-IPO Debt - Dynavax Technologies
Bill & Melinda Gates Foundation
Bill & Melinda Gates Foundation investment in Grant - Dynavax Technologies
CRG
CRG investment in Post-IPO Debt - Dynavax Technologies
Hercules Capital
Hercules Capital investment in Debt Financing - Dynavax Technologies
National Institute of Allergy and Infectious Diseases
National Institute of Allergy and Infectious Diseases investment in Grant - Dynavax Technologies
Deerfield
Deerfield investment in Post-IPO Debt - Dynavax Technologies
Alta Partners
Alta Partners investment in Series D - Dynavax Technologies
Bain Capital Life Sciences
Bain Capital Life Sciences investment in Series D - Dynavax Technologies
Care Capital
Care Capital investment in Series D - Dynavax Technologies
Forward Ventures
Forward Ventures investment in Series D - Dynavax Technologies
Key Employee Changes
| Date | New article |
|---|---|
| 2020-09-24 | Dynavax Announces Appointment of New Board Member and Planned Retirement of Chief Financial Officer |
Official Site Inspections
http://www.dynavax.com Semrush global rank: 2.14 M Semrush visits lastest month: 9.43 K
- Host name: ec2-54-176-110-96.us-west-1.compute.amazonaws.com
- IP address: 54.176.110.96
- Location: San Jose United States
- Latitude: 37.3388
- Longitude: -121.8914
- Metro Code: 807
- Timezone: America/Los_Angeles
- Postal: 95141
